Bispecific monoclonal antibody therapy (anti HER-2/neu × anti CD 64) for human breast cancers that overexpress HER-2/neu
Frank H. Valone, Peter A. Kaufman, Michael W. Fanger, Paul M. Guyre, Clark SpringgateVolume:
53
Year:
1993
Language:
english
Pages:
2
DOI:
10.1002/jcb.240531157
File:
PDF, 184 KB
english, 1993